After 18 years, MSF hands over its Drug-Resistant Tuberculosis (DR-TB) Project to the National TB Elimination Program in Mumbai
September 27, 202427 Sept 2024, Mumbai: Médecins Sans Frontières (MSF)/Doctors Without Borders today announced the planned closure of its Mumbai-based Drug-Resistant Tuberculosis (DR-TB) project by the end of 2024. This significant initiative has been providing comprehensive care to patients with complex cases...
Read moreIndia: Mumbai TB Symposium Focuses on Advancing TB Treatment and Collaboration
June 11, 202410 June 2024, Mumbai: A pivotal symposium organised today by Médecins Sans Frontières (MSF)/Doctors Without Borders brought together a diverse coalition of experts and stakeholders to forge actionable strategies against Drug-Resistant Tuberculosis (DRTB). This crucial gathering aimed to highlight the...
Read moreWorld Tuberculosis Day: Treating the untreatable
March 24, 2019With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out...
Read moreRenewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai
March 24, 2018Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB). Pooja,...
Read moreMumbai: A new life with new tuberculosis drugs
December 1, 2016Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to...
Read moreIndia: Renewed hope with new drugs
October 28, 2016Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able...
Read more